Roche Holding AG

Roche Holding AG

Roche Holding AG

Overview
Date Founded

1966

Headquarters

Grenzacherstrasse 124,Basel, Basel-Stadt (Basle Town) 4070

Type of Company

Public

Employees (Worldwide)

97.7K

Industries

Pharmaceuticals
Wholesale: Consumer Non-Durables/Sundries
IT Consulting & Services
Holding Companies
Medical Support Services
Biotechnology

Company Description

Roche Holding ag Roche Personalised Healthcare – our mission The healthcare landscape is constantly changing. Patients, physicians and payers demand safer, more effective treatments, while investors search after robust and sustainable business models. Growing demand for highly effective, impactful medicines is being driven by an aging population, healthcare and economic pressures. But an influx of new technologies enables Roche to meet this need by offering innovative tests and medicines. These healthcare drivers have led us in one direction – ‘Roche Personalised Healthcare’. At Roche, ‘Personalised Healthcare’ is at the core of our business strategy

Contact Data
Trying to get in touch with decision makers at Roche Holding AG? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chief Executive Officer

Chief Financial & Information Technology Officer

General Counsel

Chairman & Chief Executive Officer of Chugai

Secretary-Executive Committee & Head-Chief Executive Officer Office

Member of the Enlarged Corporate Executive Committee, Global Head Pharma Partnering

Head-Cancer Immunotherapy Discovery

Chief Medical Officer & Head of Global Product Development

Head-Group Communications

Global Head, Neurodegeneration

Board of Directors

Honorary Professor at University of St. Gallen

Treasurer & Director at Fondation Auxiliaire du Conservatoire botanique de la Ville de

Chief Financial & Information Technology Officer at Roche Holding AG

Chief Executive Officer at Roche Holding AG

Manager at ESCP Europe Campus Paris

Regius Professor of Medicine at Oxford University Medical School

Group Chief Executive Officer at Swiss Life Holding AG

President at The Rockefeller University

Director at Roche Holding AG

Secretary, Board of Directors at Roche Holding AG

Paths to Roche Holding AG
Potential Connections via
Relationship Science
You
Roche Holding AG
Owners & Shareholders
Details Hidden

Dodge & Cox employs in-house fundamental bottom-up research, a rigorous valuation discipline, and maintains a long-term investment horizon. Their investment decisions are made by a team of seasoned investment professionals. The firm's approach stresses an evaluation of risk relative to opportunity and they seek investments that they believe are undervalued by the market.

Details Hidden

APG follows a highly diversified approach to asset allocation and invest across a range of asset classes and regions. The firm applies a multi-alpha strategy to spread risk and seek high returns. Their internally-managed fund range includes Commodities, Developed Markets Equity, Developed Markets Equity Minimum Volatility, Emerging Markets Equity, Emerging Markets Debt, Europlus Treasuries, Hedge fund, Fixed Income Credits, Index Linked Bonds, Infrastructure, Long Duration Treasuries, Private Equity, Strategic Real Estate and Tactical Real Estate funds. Their research and documentation team initiates, formulates and evaluates active investment strategies and develops quantitative investment models used to determine the effectiveness of investment decisions. The team also acts as an advisory body for the Board and fund managers with respect to investment decisions.

Details Hidden

Trium Capital LLP, part of Trium Holdings Ltd., is a British company located in London. The firm provides investment advice. It was founded in 2013 by David Bamber.

Recent Transactions
Details Hidden

Roche Holding AG purchases Obi ApS

Details Hidden

Roche Holding AG purchases Promedior, Inc. from Forbion Capital Partners Management Holding BV, Easton Capital Investment Group, Morgenthaler Management Corp., Polaris Partners, BioMed Ventures, HealthCare Ventures LLC

Details Hidden

Roche Holding AG purchases Spark Therapeutics, Inc.

Transaction Advisors
Legal Advisor

Advised onRoche Holding AG purchases Genentech, Inc.

Investment Advisor

Advised onKoninklijke DSM NV purchases Roche Holding AG /Roche Vitamins Unit from Roche Holding AG

Investment Advisor

Advised onRoche Holding AG purchases InterMune, Inc.

Legal Advisor

Advised onRoche Holding AG purchases InterMune, Inc.

Legal Advisor

Advised onRoche Holding AG purchases InterMune, Inc.

Legal Advisor

Advised onRoche Holding AG purchases Genentech, Inc.

Advisors & Consultants
Advisor

Emeritus Professor of Medicine at Stanford University - School of Medicine

Advisor

Partner at Centerview Partners LLC

Advisor

Founder at Lassiter Consulting

Clients

Synlogic, Inc. is a clinical-stage biopharmaceutical company. It engages in drug discovery and development of synthetic biotic medicines. The firm focuses on SYNB1020 and SYNB1618, which are orally administered and target hyperammonemia and phenylketonuria. It also works on SYNB1891, an intratumorally administered which treats cancer. The company was founded by Jim Collins and Tim Lu on August 28, 2017, and is headquartered in Cambridge, MA.

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

bioMérieux SA engages in the provision of diagnostic solutions, which determine the source of disease and contamination. The company provides clinical solutions such as antimicrobial resistance, C. difficile infection, human immunodeficiency virus, and emergency department patient management. It also specializes in the field of in vitro diagnostics. The company was founded in 1963 and is headquartered in Marcy l'Etoile, France.

Key Stats and Financials As of 2019
Market Capitalization
$295B
Total Enterprise Value
$278B
Earnings Per Share
$15.77
Revenue
$61.5B
Net Profit
$13.5B
EBITDA
$23.2B
EBITDAMargin
37.76%
Total Debt
$15.6B
Total Equity
$35.9B
Enterprise Value Sales
4.53x
Enterprise Value EBITDAOperating
11.98x
TEVNet Income
20.61x
Debt TEV
0.06x
Three Year Compounded Annual Growth Rate Of Revenue
6.72%
Five Year Compounded Annual Growth Rate Of Revenue
5.31%
Investments
Details Hidden

Vaccibody is a clinical-stage biopharmaceutical company. The firm engages in discovering and developing of novel immunotherapies. It focuses on developing field of individualized cancer neoantigen vaccines by using the Vaccibody technology to generate therapeutics to treat cancer. The company was founded by Inger Sandlie and Agnete Brunsvik Fredriksen on November 22, 2006 and is headquartered in Oslo, Norway.

Details Hidden

Start Codon Ltd. engages in the provision of recruitment services for healthcare start-ups. It offers seed funding, coaching, and office space for applicants. The company was founded by Jason Mellad and Marek Tyl and is headquartered in London, the United Kingdom.

Details Hidden

Eloxx Pharmaceuticals Ltd. provides biopharmaceutical research and development services. The firm specializes in the discovery, development, and commercialization of drug compounds for the treatment of genetic diseases. It focuses on the treatment of diseases caused by nonsense mutations, including Cystic fibrosis, Duchene Muscular Dystrophy, Usher syndrome, Ataxia-telangiectasia, Beta thalassemia, and Tay-Sachs Hurler syndrome. Its focus areas encompass clinical drug development and target drugs discovery programs. The company was founded by Silvia Noiman and Shmuel Tuvia in 2013 and is headquartered in Herzliya, Israel.

Investors
Details Hidden

Partner at Lowenstein Sandler LLP

Details Hidden

Co-Founder & Chief Executive Officer at Fundera, Inc.

Details Hidden

Chairman at Jello Labs, Inc.

Suppliers
Alexandria Real Estate Equities, Inc. Trusts & Funds | Pasadena, CA

Alexandria Real Estate Equities, Inc. is an urban office real estate investment trust, which engages in the ownership, operation, development, and redevelopment of life science and technology properties. It also provides a space for lease to the life science and technology industries which are primarily located in AAA urban innovation cluster locations. The company was founded by Alan D. Gold, Gary A. Kreitzer, Joel S. Marcus, and Jerry M. Sudarsky in October 1994 and is headquartered in Pasadena, CA.

Xenon Pharmaceuticals, Inc. Pharmaceuticals | Burnaby, Canada

Xenon Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It develops therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system (CNS) conditions. The company's products include XEN496, XEN1101, XEN901 and XEN007. Xenon Pharmaceuticals was founded by Simon Neil Pimstone, Johannes J. P. Kastelein and Michael R. Hayden on November 5, 1996 and is headquartered in Burnaby, Canada.

Exelixis, Inc. Hospitals & Patient Services | South San Francisco, CA

Exelixis is a biopharmaceutical company committed to developing and commercializing small molecule therapies for the treatment of cancer. In advancing our first product, COMETRIQ, from discovery to market, we have established an effective and integrated infrastructure that encompasses the entire biopharmaceutical development continuum. We are committed to excellence in all aspects of our work and are dedicated to improving the care and outcome of cancer patients.

Competitors
Merck & Co., Inc. Pharmaceuticals - Kenilworth, NJ

Merck & Co., Inc. , d.b.a. Merck Sharp & Dohme, MSD outside the United States and Canada, is an American pharmaceutical company and is one of the largest pharmaceutical companies in the world.

Johnson & Johnson Pharmaceuticals - New Brunswick, New Jersey

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Abbott Laboratories Pharmaceuticals - Abbott Park, Illinois

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, Cardiovascular and Neuromodulation Products, and Other. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Vascular Products segment trades coronary, endovascular, structural heart, vessel closure, and other medical device products. The Other segment comprises of Abbott Medical Optics. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Roche Holding AG. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Roche Holding AG's profile does not indicate a business or promotional relationship of any kind between RelSci and Roche Holding AG.